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n mammalian cells, the Golgi apparatus undergoes exten-
sive fragmentation during apoptosis. p115 is a key vesicle
tethering protein required for maintaining the structural
organization of the Golgi apparatus. Here, we demonstrate
that p115 was cleaved during apoptosis by caspases 3 and 8.
Compared with control cells expressing native p115, those
expressing a cleavage-resistant form of p115 delayed Golgi
fragmentation during apoptosis. Expression of cDNAs encod-
ing full-length or an NH
 
2
 
-terminal caspase cleavage fragment
of p115 had no effect on Golgi morphology. In contrast,
Î
 
expression of the COOH-terminal caspase cleavage product
of p115 itself caused Golgi fragmentation. Furthermore, this
fragment translocated to the nucleus and its expression was
sufﬁcient to induce apoptosis. Most signiﬁcantly, in vivo
expression of the COOH-terminal fragment in the presence
of caspase inhibitors, or upon coexpression with a cleavage-
resistant mutant of p115, showed that p115 degradation
plays a key role in amplifying the apoptotic response indepen-
dently of Golgi fragmentation.
 
Introduction
 
In most eukaryotic cells, the Golgi apparatus exists as a series
of flattened membrane stacks arranged in a perinuclear lace-
like reticulum. Recently, several proteins that maintain the
characteristic morphology of the Golgi apparatus during
interphase have been characterized (Linstedt and Hauri, 1993;
Barroso et al., 1995; Nakamura et al., 1995; Barr et al., 1997;
Lowe et al., 2000; Weide et al., 2001). A tightly membrane-
associated peripheral Golgi protein, GM130, was shown to
bind p115/transcytosis-associated protein, a vesicle tethering
protein localized to the Golgi apparatus and vesicular tubular
clusters. In turn, p115 interacts with a high molecular weight
vesicle-associated protein, designated giantin (Nakamura et
al., 1997; Lesa et al., 2000; Moyer et al., 2001). According to
one model, by linking GM130 and giantin, p115 tethers
vesicles to the Golgi apparatus to facilitate membrane fusion
and allow maintenance of the Golgi architecture (Seemann et
al., 2000). Considerable evidence has accumulated demon-
strating that GM130 is phosphorylated during mitosis (Lowe
et al., 1998b, 2000; Garcia-Mata et al., 2000). Phosphorylated
GM130 can no longer interact with p115, thereby abolishing
Golgi vesicle tethering and fusion (Nakamura et al., 1997). It
has been proposed that continual budding of vesicles in the
absence of fusion leads to mitotic fragmentation of the Golgi
apparatus (Lowe et al., 1998a). Although other models for
Golgi apparatus disassembly have been proposed (Zaal et al.,
1999), very recent evidence (Puthenveedu and Linstedt, 2001)
suggests that p115, but not giantin and GM130, is essential for
maintaining the architecture of the Golgi apparatus.
Various agents induce fragmentation of the Golgi apparatus,
including those causing apoptosis (Takizawa et al., 1993;
Monier et al., 1998; de Figueiredo et al., 1999; Sesso et al.,
1999; Siddhanta et al., 2000)
 
.
 
 Apoptosis is an organized
form of cell death characterized by cell shrinkage, nuclear
condensation, and formation of apoptotic bodies (Strasser et al.,
2000). Many of these changes result from cleavage of organelle
proteins by caspases, a family of cysteine proteases activated
during the apoptotic response, all of which have an absolute
requirement for cleavage after an aspartic acid residue
(Thornberry et al., 1997). Among the organelles affected
during apoptosis is the Golgi apparatus, which fragments
into small vesiculo-tubular elements (Sesso et al., 1999).
Golgin-160, a member of a family of high molecular weight
Golgi-associated coiled-coil proteins implicated in maintaining
the Golgi structure, was shown to be cleaved by caspases 2,
3, and 7 during apoptosis (Mancini et al., 2000). Most recently,
GRASP65, a protein involved in the stacking of Golgi cisternae,
was also shown to be cleaved by caspase-3 during the apoptotic
response (Lane et al., 2002). Expression of a golgin-160 mutant
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lacking the caspase-2 cleavage site or a GRASP65 construct
mutated at three caspase-3 sites delayed, but did not inhibit,
apoptotic Golgi fragmentation (Mancini et al., 2000; Lane
et al., 2002), suggesting that multiple factors regulating
Golgi structure are affected during apoptosis.
The
 
 
 
morphology of apoptotic and mitotic Golgi fragments
is similar (Sesso et al., 1999); it is therefore possible that they
are generated by similar mechanisms. To investigate this pos-
sibility, we have analyzed the role of GM130 and p115 during
apoptotic Golgi fragmentation. Here we show that in contrast
to mitosis, no change in GM130 phosphorylation was de-
tected in apoptotic cells. Instead, the level of GM130 de-
creased significantly and p115 underwent selective proteolytic
cleavage via caspases 3 and 8. A stable cell line expressing a
cleavage-resistant form of p115 delayed Golgi fragmentation
during apoptosis. Furthermore, expression of a region of p115
corresponding to a COOH-terminal apoptotic cleavage frag-
ment was sufficient to disrupt the structure of the Golgi appa-
ratus. Strikingly, this fragment also translocated into the nu-
cleus and activated the apoptotic program. Our data suggest
that caspase-mediated proteolysis of key vesicle tethering fac-
tors contributes to Golgi breakdown during apoptosis and
may act to propagate downstream apoptotic signals.
 
Results
 
Fragmentation of the Golgi apparatus during apoptosis 
is independent of GM130 phosphorylation
 
Phosphorylation of GM130 at serine 25 has been shown to
be a key step in regulating the structure of the Golgi appa-
ratus during mitosis (Lowe et al., 1998b). We therefore
tested whether the mechanisms of mitotic and apoptotic
Golgi fragmentation might be similar. Given that staurospor-
ine, a general protein kinase inhibitor, induces apoptosis
and Golgi fragmentation (Fig. S1, available at http://
www.jcb.org/cgi/content/full/jcb.200208013/DC1), it was
unlikely that GM130 would be phosphorylated. However,
to eliminate this possibility, an antibody (PS25) that is
highly specific for the phosphorylated form of GM130 was
employed for immunofluorescence microscopy. As previ-
ously demonstrated (Lowe et al., 2000), PS25 immunostain-
ing was present in mitotic Golgi fragments, but not in the
Golgi apparatus of interphase cells. In sharp contrast to mi-
totic cells, the PS25 antibody failed to stain apoptotic cells
treated with either staurosporine or etoposide (Fig. 1). Iden-
tical results were obtained when the PS25 antibody was used
for Western blot analysis (unpublished data).
 
p115 and GM130 levels decrease during apoptosis
 
The above result did not exclude the possibility that Golgi
fragmentation involved alternative modifications other than
phosphorylation of vesicle tethering factors. Because many
proteins involved in the maintenance of cellular structure are
cleaved by caspases during apoptosis, we reasoned that
GM130 and p115 might undergo proteolysis during apop-
tosis. If this generated nonfunctional fragments of these fac-
tors, it could result in the Golgi breakdown seen in apopto-
sis. To test this idea, apoptosis was induced in COS7 cells
and, at various times, total cell extracts were analyzed by
Western blots using antibodies to GM130 and p115 (Fig.
2 A). A significant decrease in both GM130 and p115 lev-
els was observed during the time course. Importantly, a
polypeptide of 
 
 
 
90,000 D (90 kD) that cross-reacted with
the p115 antibody was evident in apoptotic cell lysates (Fig.
2 A). This 90-kD polypeptide was also recognized by three
independent p115 monoclonal antibodies in lysates from
apoptotic COS7 cells (unpublished data). Moreover, an an-
tibody that specifically recognizes the COOH terminus of
p115 revealed a polypeptide of 
 
 
 
30,000 D (30 kD) in apop-
totic cell lysates (Fig. 2 A). The time-dependent appear-
ance of these polypeptides corresponded to decreases in the
level of full-length p115 during apoptosis (Fig. 2 B), sug-
gesting a precursor–product relationship. Significantly, even
though staurosporine and etoposide induce apoptosis by dif-
ferent modes of action, identical p115-immunoreactive
polypeptides were generated. The appearance of these
polypeptides also coincided with the cleavage of poly(ADP-
ribose) polymerase (PARP)* (Fig. 2 A), a classic marker of
apoptosis. In contrast, the level of the Golgi SNARE protein
Figure 1. Fragmentation of the Golgi apparatus during apoptosis 
is independent of GM130 phosphorylation. Apoptotic NRK cells 
were induced with staurosporine for 12 h or etoposide for 24 h. The 
cells were then processed for immunofluorescence microscopy 
and examined using rabbit anti-PS25 antibodies specific for the 
phosphorylated form of GM130 (red) (Lowe et al., 2000). Nuclei 
were stained with Hoechst 33238 (blue). As a positive control, NRK 
cells were synchronized at mitosis using aphidicolin (Lowe et al., 
2000). Note the appearance of phosphorylated GM130 only in 
mitotic cells. Bar, 10  m.
 
*Abbreviations used in this paper: NRK, normal rat kidney; PARP,
poly(ADP-ribose) polymerase. 
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Vti1a remained constant throughout the entire apoptosis
time course (Fig. 2 A). The above results suggested that the
p115-immunoreactive polypeptides (90 and 30 kD) repre-
sent apoptotic cleavage fragments of p115. However, it
might be argued that the proteolysis of p115 was a conse-
quence of nonphysiological effects induced by staurosporine
and etoposide. To exclude this possibility, apoptosis was in-
duced in HeLa cells by activation of the Fas receptor using
agonistic anti-Fas antibodies (Fig. 2 C). In agreement with
the above data, ligation of the Fas receptor resulted in p115
cleavage and a significant decrease in its level (Fig. 2 C, lanes
2 and 3), indicating that the foregoing results are indeed rel-
evant physiologically.
 
p115 is cleaved by caspases 3 and 8 during apoptosis
 
To determine if the p115-immunoreactive polypeptides re-
sulted from the cleavage activity of caspases, COS7 cells
were preincubated with caspase inhibitors before apoptosis
induction. At the indicated times (Fig. 2 D), cell lysates were
analyzed by Western blotting using anti-p115 antibodies. In
cells preincubated with the general caspase inhibitor z-VAD-
fmk, the formation of the 90- (Fig. 2 D) and 30-kD (un-
published data) p115 polypeptides was completely abro-
gated. In contrast, the polypeptides were clearly visible in
control samples preincubated with DMSO alone or with
z-YVAD-fmk (Fig. 2 D). z-YVAD-fmk has weak inhibitory
effects on the apoptotic caspases but it is a potent inhibitor
of caspases involved in the immune system (caspases 1 and
4). These results strongly suggest that the 90- and 30-kD
polypeptides are caspase cleavage fragments of p115 gener-
ated during apoptosis.
To confirm that p115 was a direct target of apoptotic
caspases, mRNA encoding full-length human p115 was
translated in vitro and the products were incubated with var-
ious purified caspases (Fig. 3 A). Treatment with caspase-3
generated p115 fragments of 90, 75, 50, and 30 kD, whereas
incubation with caspase-8 yielded only the 90- and 30-kD
fragments. In contrast, caspases 2 and 7 did not cleave p115
in vitro, even after prolonged incubation. Similarly, caspases
3 and 8, but not caspases 2 and 7, cleaved in vitro–translated
bovine p115 to generate the same proteolytic fragments as
human p115 (Fig. 3 B). Note that the 90- and 30-kD frag-
ments reached maximum levels after only 10 min of incuba-
tion, whereas the 75- and 50-kD polypeptides were slowly
generated over a period of 90–120 min (Fig. 3 C). The 90-
and 30-kD fragments generated in vitro corresponded in size
to the p115-derived polypeptides present in apoptotic COS7
cell lysates (Fig. 2 A). Together, these data suggest that in
vivo, the 90- and 30-kD fragments are derived from the
main caspase cleavage site in p115 (see Discussion).
 
The 90- and 30-kD fragments are generated by 
cleavage of p115 at position TEKD
 
757
 
We used site-directed mutagenesis to identify caspase cleav-
age sites on p115. Based on our in vivo and in vitro data, the
90- and 30-kD fragments were likely to be products of the
most prominent p115 caspase cleavage site. Western blot
analysis of apoptotic cells transfected with an NH
 
2
 
-terminal
FLAG-tagged p115 construct indicated that the 90-kD frag-
Figure 2. The levels of GM130 and p115 decrease during apoptosis. 
p115 is cleaved by caspases into two fragments. (A) COS7 cells 
were incubated with staurosporine or etoposide. At the indicated 
times, cell lysates were prepared for Western blotting using antibodies 
to GM130, p115, PARP, or the Golgi SNARE, Vtila. p115 antibodies 
revealed two polypeptides of 90 and 30 kD in apoptotic lysates. 
(B) Quantitation of GM130 and p115 breakdown and the appearance 
of the 90- and 30-kD polypeptides in staurosporine- and etoposide-
treated cells. Note that the appearance of the 90- and 30-kD 
polypeptides coincided with the decrease in full-length p115, 
suggesting a precursor product relationship. (C) HeLa cells were 
treated with activating anti-Fas antibodies and cycloheximide 
(C. F.). Cell lysates were prepared 24 or 48 h after treatment and 
analyzed by Western blotting using an antibody to p115. Unlike 
control samples treated with cycloheximide alone, the p115 levels 
of cells incubated with both anti-Fas antibodies and cycloheximide 
were decreased. (D) Lysates were prepared from COS7 cells treated 
with staurosporine or etoposide for the indicated times in the presence 
of z-VAD-fmk or z-YVAD-fmk. Lysates were analyzed by Western 
blotting using an antibody to p115. Generation of the 90-kD 
polypeptide in apoptotic cell lysates was inhibited in the presence 
of the apoptotic caspase inhibitor z-VAD-fmk. 
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ment contained the NH
 
2
 
 terminus (Fig. 3 D, lanes 1–3).
Therefore, we analyzed the human p115 sequence for poten-
tial caspase cleavage sites toward the COOH terminus that
would result in an NH
 
2
 
-terminal fragment of 
 
 
 
90 kD.
Three such sites, SEED
 
635
 
, REQD
 
663
 
, and TEKD
 
757
 
, were
identified and their aspartic acid residues mutated separately
to alanine. The mRNA encoding each alanine mutant was
then translated in vitro and the products incubated with
caspase-3. Two of the mutants, SEED
 
635Ala
 
 and REQD
 
663Ala
 
,
generated proteolytic fragments identical to those of native
p115, suggesting that these sites were not targets of caspase-3
cleavage (unpublished data). Significantly, caspase-3 failed
to release the 90- and 30-kD fragments in the third p115
mutant, TEKD
 
757Ala
 
 (Fig. 3 C). This mutant also failed to
generate these fragments when incubated with caspase-8
(unpublished data). In addition, production of the 75- and
50-kD fragments was not affected in this mutant. To con-
firm that p115 was also cleaved at position TEKD
 
757
 
 in vivo,
COS7 cells were transiently transfected with either the wild
type or the TEKD
 
757Ala
 
 mutant, both of which were FLAG
tagged at the NH
 
2
 
 terminus. Apoptosis was then induced using
staurosporine or etoposide (Fig. 3 D). In contrast to wild-type
p115 (lanes 1–3), Western blot analysis of the mutant p115 us-
ing anti-FLAG antibodies showed that it was not cleaved in
vivo (lanes 4–6). Together these in vitro and in vivo data indi-
cate that the TEKD
 
757
 
 cleavage site was responsible for generat-
ing the 90- and 30-kD cleavage fragments of p115.
To further elucidate the role of caspase-3 in mediating
p115 cleavage, we used MCF-7 cells, which are devoid of
this enzyme (Janicke, et al., 1998) (Fig. 3 E). As expected,
these cells were quite resistant to apoptosis because of the
lack of caspase-3. The levels of p115 in apoptotic MCF-7
cell lysates were compared with those of BID, an early apop-
totic signaling molecule cleaved by caspase-8. Although BID
cleavage is detected early in cells treated with agonistic anti-
Fas antibodies, its cleavage occurred only after prolonged in-
cubation in cells treated with staurosporine and etoposide.
The kinetics of p115 and BID cleavage (Fig. 3 E) were simi-
lar in staurosporine- and etoposide-treated cells. However,
BID cleavage was more efficient than p115 in MCF-7 cells
stimulated by Fas receptor ligation. These data suggest that
in addition to caspase-3, other caspases may be involved in
p115 cleavage in vivo.
 
Cleavage of p115 contributes to Golgi fragmentation 
during apoptosis
 
Given the importance of p115 in maintaining normal Golgi
structure (Shorter and Warren, 1999) and in membrane
transport to and within the Golgi apparatus (Alvarez et al.,
1999; Seemann et al., 2000), we reasoned that its cleavage
was at least partly responsible for the fragmentation seen
during apoptosis. If this were the case, expression of a cleav-
age-resistant form of p115 would be expected to delay frag-
mentation of the Golgi apparatus. To test this idea, stable
COS7 cell lines expressing low levels of wild-type p115 or
the TEKD
 
757Ala
 
 mutant were generated and treated with eto-
poside for 24 h. After treatment, cells were stained with an
antibody to GM130 and the number of cells displaying a
fragmented Golgi staining pattern was quantified (Fig. 4;
Table I). The Golgi apparatus of untreated COS7 cells ex-
hibited a perinuclear localization where staining was tight
and reticular (Fig. 4 A, left). After etoposide treatment for
24 h, cells displaying two distinct stages of Golgi fragmenta-
tion were clearly visible. In stage one, Golgi fragmentation
was at an intermediate phase, where the Golgi staining is
Figure 3. p115 is cleaved by caspases-3 in vitro 
and in vivo at residue TEKD757 to generate the 90- 
and 30-kD fragments. (A) In vitro–translated 
human p115 mRNA was incubated with various 
caspases for 1 h at 37 C. p115 was cleaved by 
purified caspase-3 into four fragments of 90, 75, 
50, and 30 kD. Caspase-8 generated only the 90- 
and 30-kD fragments. (B) In vitro–translated bovine 
p115 mRNA was incubated with the same 
caspases as human p115. Numbers at the top 
indicate the concentration (nM) of caspase in each 
reaction. (C) In vitro–translated human p115 
mRNA was incubated with caspase-3 for the 
indicated times (min). For wild-type p115 (left), the 
90- and 30-kD fragments were rapidly generated 
after 10 min of incubation. In contrast, the 75- and 
50-kD fragments required prolonged incubation 
before reaching a plateau. For the p115 TEKD757Ala 
mutant (right), the appearance of the 90- and 30-kD 
fragments was completely abrogated, whereas the 
75- and 50-kD fragments were unaffected. Asterisks 
indicate an incomplete translation product of p115. 
(D) COS7 cells were transfected with NH2-terminal 
FLAG constructs of wild-type p115 or the p115 
TEKD757Ala mutant. 24 h after transfection, apoptosis 
was induced with staurosporine or etoposide for 
the indicated times. Lysates were prepared and analyzed by Western blotting using polyclonal FLAG antibodies. Wild-type p115, unlike the 
p115 TEKD757Ala mutant, was cleaved to generate the 90-kD fragment. (E) MCF-7 cells were treated with staurosporine, etoposide, cycloheximide 
(C.), or agonistic anti-Fas antibodies plus cycloheximide (C. F.) for the indicated times. Cell lysates were prepared and Western blot analysis 
was performed using antibodies to p115 and BID. 
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loose but maintains a reticular and perinuclear distribution
(Fig. 4 A, middle). In stage two, no perinuclear staining was
evident and Golgi fragments appeared as punctate structures
dispersed throughout the cell (Fig. 4 A, right). When com-
pared with control cells expressing wild-type p115, cells ex-
pressing the TEKD
 
757Ala
 
 mutant had a modest effect in de-
laying the progression from normal to stage one of Golgi
fragmentation (Fig. 4 B; Table I). In contrast, the transition
from stage one to stage two of Golgi fragmentation was sig-
nificantly delayed by more than twofold (Fig. 4 B; Table I).
These results strongly support our hypothesis that caspase-3
cleavage of p115 is a key step in the fragmentation of the
Golgi apparatus during apoptosis.
 
Expression of the COOH-terminal caspase cleavage 
fragment of p115 disrupts the Golgi apparatus and 
induces apoptosis
 
We reasoned that if p115 is required to maintain the normal
Golgi structure, then expression of the p115 caspase cleavage
fragments may have a dominant negative effect on the en-
dogenous protein, resulting in Golgi fragmentation. To de-
termine if cleavage at TEKD
 
757
 
 was by itself sufficient to
disrupt the structural integrity of the Golgi apparatus, full-
length p115 as well as two truncation mutants correspond-
ing to the NH
 
2
 
- and COOH-terminal p115 caspase cleavage
fragments (i.e., p115
 
1–757
 
 and p115
 
758–962
 
, respectively) were
expressed as FLAG-tagged proteins in COS7 cells. At various
times after transfection, the cells were examined by immuno-
fluorescence microscopy (Fig. 5). Transfected cells were
identified by staining with a monoclonal antibody to the
FLAG epitope, and the Golgi apparatus was monitored us-
ing a polyclonal antibody against TGN38. At 20 h after
transfection, the FLAG staining for full-length p115 colocal-
ized tightly with the Golgi apparatus. There was also a minor
level of diffuse staining throughout the cytoplasm (Fig. 5).
Similarly, the NH
 
2
 
-terminal p115
 
1–757
 
 construct had an in-
tracellular localization identical to that of full-length p115,
with the exception of a slightly more diffuse cytoplasmic
staining; however the bulk of its staining colocalized with the
Golgi apparatus (Fig. 5). This is consistent with previous ob-
servations showing that the COOH-terminal acidic domain
is not required for the localization of p115 to the Golgi ap-
paratus and vesiculo-tubular clusters (Nelson et al., 1998).
Importantly, in cells expressing this mutant, the Golgi appa-
ratus had a normal morphology at 20 h after transfection, as
monitored by TGN38 staining (Fig. 5; Table II). Identical
results were obtained when giantin was used as the Golgi
marker (unpublished data). This indicates that either p115 is
not required for maintenance of Golgi structure or the
Figure 4. Classification of Golgi 
morphology during apoptosis. 
(A) Untreated COS7 cells (left) were 
fixed and stained with a monoclonal 
antibody against GM130 (green). Nuclei 
were stained with Hoechst 33238 (blue). 
Note the tight perinuclear Golgi staining 
of untreated cells. After etoposide 
treatment for 24 h, two populations 
of cells were distinguished. In one 
population (middle), the Golgi apparatus 
is at an early stage of fragmentation 
where staining is loose, but still reticular 
and perinuclear. In the second population, 
the Golgi apparatus is completely 
dispersed and the resulting membrane 
fragments stain as punctate structures 
(right). (B) COS7 cells transfected with 
either wild-type p115 or the p115 
TEKD757Ala mutant were treated with 
etoposide for 24 h. Cells were then stained 
and processed as above. Expression of 
the p115 TEKD757Ala mutant delayed both 
stages of Golgi fragmentation compared 
with control cells expressing wild-type 
p115. Bar, 10  m.
 
Table I. 
 
Percentage of transfected COS7 cells displaying various Golgi morphologies after etoposide treatment for 24 h
Transfected construct Tight and reticular Loose and reticular Dispersed and punctate
 
%% %
 
Wild-type p115 18.4 42.9 38.7
TEKD
 
757Ala
 
 p115 24.0 58.3 17.3
Results are the averages of duplicate samples from two separate experiments. In each case, 1,400 cells were counted by two independent observers. The
expression levels of the wild-type and TEKD
 
757Ala
 
 p115 were identical, as determined by Western blot analysis (unpublished data). 
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p115
 
1–757
 
 mutant failed to act as a dominant negative and
therefore did not disrupt the normal function of endogenous
p115. In marked contrast to the expression of full-length
p115 or the p115
 
1–757
 
 mutant, nearly every cell expressing
the COOH-terminal p115
 
758–962
 
 mutant displayed a frag-
mented Golgi staining pattern (Fig. 5; Table II). This result
strongly suggests that the p115
 
758–962
 
 mutant competed with
endogenous p115 for binding to critical factors required for
maintaining the normal Golgi architecture. Strikingly, most
cells (
 
 
 
78%) expressing the p115
 
758–962
 
 construct were apop-
totic, as determined by chromatin condensation and cell
shrinkage (Table II). In contrast, expression of neither native
p115 nor p115
 
1–757
 
 induced apoptosis (Fig. 5; Table II).
Quite unexpectedly, in addition to its dispersed cytoplasmic
distribution, p115
 
758–962
 
 was highly enriched in apoptotic
cell nuclei, where its staining colocalized perfectly with local
 
DNA densities. Examination of 
 
 
 
250 cells revealed that
76% of all p115
 
758–962
 
-transfected cells had significant levels
of the protein in the nucleus. In sharp contrast, no nuclear
localization of the expressed protein was present in any of the
cells transfected with either the full-length p115 or the
p115
 
1–757
 
 construct at all time points examined.
To ensure that the cells expressing the COOH-terminal
p115
 
758–962
 
 fragment were indeed apoptotic, HeLa cells were
transfected with either the NH
 
2
 
- or COOH-terminal p115
fragments and then stained for the presence of several apop-
totic markers (Fig. 6). Transfected cells were identified by
coexpression of a GFP cDNA. Apoptotic cells were identi-
fied by staining with polyclonal antibodies specific for the
cleaved p17 fragment of caspase-3 or the cleaved p85 frag-
ment of PARP. These antibodies do not stain uncleaved
forms of these proteins in healthy cells. There was no stain-
Figure 5. The COOH-terminal cleavage 
fragment of p115 induces Golgi 
fragmentation and apoptosis. COS7 
cells were transfected with FLAG-tagged 
full-length p115, NH2-terminal fragment 
(p1151–757), or COOH-terminal fragment 
(p115758–962). Cells were fixed 20 h 
after transfection and stained with a 
TGN38 (green) antibody, a FLAG (red) 
antibody, and Hoechst 33238 (blue). 
Full-length p115 and p1151–757 localized 
predominantly to the Golgi region and 
their expression did not affect Golgi 
morphology or cell viability in transfected 
cells. In contrast, p115758–962 staining 
was diffuse in the cytoplasm and 
concentrated in the nucleus. Most 
significantly, expression of p115758–962 
induced Golgi fragmentation and 
apoptosis, as indicated by TGN38 and 
Hoechst staining, respectively. The 
“single cell” panels show enlarged 
merged images of a representative cell 
transfected with each construct. Arrows 
indicate transfected cells. Bars, 10  m. 
 
 
Role of p115 in Golgi fragmentation and apoptosis |
 
 Chiu et al. 643
 
ing of either cleaved PARP or activated caspase-3 in cells ex-
pressing the NH
 
2
 
-terminal p115
 
1–757
 
 fragment (Fig. 6, A
and B, top). Furthermore, nuclear and cellular morphology
were normal, as indicated by Hoechst staining and phase
contrast microscopy, respectively. In sharp contrast, most
cells expressing the p115 COOH-terminal p115
 
758–962
 
 frag-
ment displayed cell shrinkage and chromatin condensation,
as shown above (Fig. 5; Fig. 6, A and B, bottom). Most sig-
nificantly, these cells also stained positive for cleaved PARP
and activated caspase-3, indicating that they were indeed ap-
 
Table II. 
 
Fragmentation of the Golgi apparatus and apoptosis in COS7 cells transfected with cDNAs encoding full-length or p115 fragments
Time after transfection
20 h 33 h
Transfected constructs Golgi fragmented Apoptotic Golgi fragmented Apoptotic
 
%%%%
 
Full-length p115 8.0 6.0 14.0 11.3
NH
 
2
 
-terminal fragment 4.6 4.1 13.8 10.6
COOH-terminal fragment 81.2 77.6 86.5 79.2
Results are the averages of duplicate samples from two separate experiments. In each case, 150 cells were counted by two independent observers.
Figure 6. Expression of the COOH-terminal caspase cleavage fragment of p115 induces caspase activation and apoptosis. (A) HeLa cells 
were cotransfected with vectors expressing GFP and either the NH2- or COOH-terminal caspase cleavage fragment of p115. At 24 h after 
transfection, cells were processed for immunofluorescence microscopy and stained with Hoechst 33238 (blue) and a polyclonal antibody 
that recognizes only the p85 caspase cleavage fragment of PARP (red). Transfected cells were identified by GFP fluorescence (green). Cells 
expressing the p115 NH2-terminal cleavage fragment did not stain for cleaved PARP, had normal nuclear staining, and were morphologically 
indistinguishable from untransfected cells (top). In sharp contrast, cells expressing the COOH-terminal cleavage fragment of p115 were positive 
for cleaved PARP and displayed additional apoptotic features including chromatin condensation and cell shrinkage (bottom). (B) HeLa cells 
were transfected and processed as above. Fixed cells were stained with Hoechst 33238 (blue) and a polyclonal antibody that specifically 
recognizes the p18 subunit of activated caspase-3 but not procaspase-3 (red). Transfected cells (green) expressing the COOH-terminal 
(bottom), but not the NH2-terminal (top), caspase cleavage fragment of p115 stained for the activated caspase-3 antibody. Arrows indicate 
transfected cells. Bar, 10  m. 
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optotic (Fig. 6, A and B, bottom). These results strongly
support our hypothesis that the COOH-terminal p115 frag-
ment is a potent mediator of apoptosis.
Because expression of the p115 COOH-terminal frag-
ment itself induced apoptosis, it could be argued that the
Golgi fragmentation resulted from apoptosis rather than an
independent, dominant negative effect on endogenous
p115. In addition, the appearance of the p115 COOH-ter-
minal fragment in the nucleus could have resulted from its
free diffusion through a more permeable nuclear membrane
during apoptosis (Faleiro and Lazebnik, 2000). To exclude
these possibilities, COS7 cells were incubated with the
caspase inhibitor z-VAD-fmk before transfection of the
p115 COOH-terminal fragment in order to inhibit apopto-
sis (Fig. 7 A, bottom). In the presence of z-VAD-fmk, the
COOH-terminal fragment still translocated to the nucleus
but failed to induce apoptosis. Furthermore, 76.5% of these
cells displayed complete vesiculation of the Golgi apparatus
even though apoptosis was inhibited (Table III). In contrast,
 
 
 
90% of the cells transfected with the COOH-terminal
fragment alone were apoptotic and displayed Golgi fragmen-
tation (Fig. 7 A, top; Table III). These data indicate that the
translocation of the p115 COOH-terminal fragment into
the nucleus and its ability to disrupt normal Golgi structure
occur independently of apoptosis.
It was possible that the apoptosis induced by expression of
the p115 COOH-terminal fragment resulted indirectly
from disruption of normal Golgi function. To eliminate this
possibility, COS7 cells were cotransfected with cDNAs en-
coding the full-length p115 TEKD
 
757Ala
 
 uncleavable mutant
and the p115 COOH-terminal fragment in a 10:1 ratio.
This ensured that cells expressing the COOH-terminal frag-
ment (identified by FLAG staining in the nucleus) also coex-
pressed the uncleavable mutant. Our rationale was that the
uncleavable mutant, which slows the rate of Golgi fragmen-
tation (Table I), should protect against fragmentation of the
Figure 7. The COOH-terminal caspase cleavage fragment of p115 induces Golgi fragmentation and apoptosis independently. (A) COS7 
cells were pretreated with DMSO alone (top) or z-VAD-fmk (bottom) and then transfected with a FLAG-tagged construct of the p115 COOH-
terminal fragment. 20 h after transfection, cells were fixed and stained with a FLAG (red) antibody, a GM130 (green) antibody, and Hoechst 
33238 (blue). Transfected cells pretreated with z-VAD-fmk were not apoptotic but displayed extensive Golgi fragmentation and nuclear 
localization of the COOH-terminal fragment. (B) COS7 cells were cotransfected with FLAG-tagged versions of the p115 TEKD757Ala mutant 
and the COOH-terminal p115 fragment in a 10:1 ratio. Cells were fixed 20 h after transfection and stained as above. Cotransfected cells that 
were apoptotic (arrows) but displayed normal Golgi morphology were clearly present. (C) Cells were transfected with a FLAG-tagged 
construct of the COOH-terminal fragment lacking the acidic region (p115 TEKD757–933) and stained as above. Note that the transfected cell on 
the left (arrow) is in the early stages of apoptosis and the cell on the right (arrow) is at a later stage. Arrows indicate transfected (A and C) or 
cotransfected (B) cells. Bar, 10  m. 
 
 
Role of p115 in Golgi fragmentation and apoptosis |
 
 Chiu et al. 645
 
Golgi apparatus induced by the p115 COOH-terminal frag-
ment. However, apoptosis would still occur in transfected
cells if cell death were not a result of Golgi fragmentation.
Our data demonstrate that this was indeed the case (Fig. 7
B; Table III). 24 h after transfection, 
 
 
 
80% of the cotrans-
fected cells were apoptotic. However, only 59.5% of these
apoptotic cells exhibited a fragmented Golgi apparatus,
compared with 
 
 
 
90% of cells expressing the COOH-termi-
nal fragment alone, i.e., Golgi breakdown was significantly
delayed. Identical results were obtained when TGN38
was used as a Golgi marker instead of GM130 (Fig. S2,
available online at http://www.jcb.org/cgi/content/full/
jcb.200208013/DC1).
To define which region of the p115 COOH-terminal
fragment was responsible for inducing apoptosis and/or
Golgi fragmentation, a truncated form of the molecule was
generated. Our initial construct removed the last 29 residues
of the COOH-terminal fragment, generating a molecule
corresponding to residues 757–933 of p115; this deleted the
acidic domain implicated in giantin–GM130 interactions
(Nakamura et al., 1997; Linstedt et al., 2000). When this
truncated fragment was expressed in COS7 cells (Fig. 7 C),
it behaved identically to the complete COOH-terminal frag-
ment, i.e., it localized to the nucleus, induced apoptosis, and
led to Golgi fragmentation. Together, our data demonstrate
that p115 plays a major role in the maintenance of the archi-
tecture of the Golgi apparatus, and its cleavage during apop-
tosis contributes to Golgi fragmentation and activation of
downstream apoptotic signals.
 
Discussion
 
Here, we have shown that the Golgi apparatus fragments
into distinct clusters of small vesicular and tubular structures
during apoptosis. In contrast to mitosis, GM130 was not
phosphorylated, although its level was diminished signifi-
cantly. Strikingly, p115, a Golgi-associated polypeptide im-
plicated in mediating several vesicle transport and docking
steps (Waters et al., 1992; Sztul et al., 1993; Barroso et al.,
1995), was cleaved by caspases in a time-dependent manner
that correlated with fragmentation of the organelle and the
onset of apoptosis. Preliminary data from our laboratory in-
dicate that GM130 is also cleaved by caspases into several
fragments in vitro. Our data demonstrate that the same
Golgi proteins (p115 and GM130) can be differentially
modified to effect quite distinct changes in the structural in-
tegrity of the Golgi apparatus. In mitosis, phosphorylation
regulates the reversible breakdown of the organelle to ensure
partitioning into daughter cells, whereas, in apoptosis, pro-
teolytic cleavage results in irreversible Golgi fragmentation
and eventually cell death.
In vitro experiments using purified caspases demonstrated
that p115 was a potent substrate for caspases 3 and 8. Both
of these enzymes cleaved p115 to generate two fragments of
90 and 30 kD. Several lines of evidence suggest that these
two polypeptides were derived from either the major or only
caspase cleavage site in p115 in vivo. First, in apoptotic cell
lysates, the 90- and 30-kD polypeptides were detected in
vivo using four different p115 antibodies (Fig. 2 A). In con-
trast, the 75- and 50-kD fragments were detected only in
vitro (Fig. 3) and no immunoreactive species of these sizes
were observed in vivo using any of the p115 antibodies. Sec-
ond, incubation of in vitro–synthesized bovine or human
p115 with caspase-8 generated only the 90- and 30-kD frag-
ments (Fig. 3, A and B). Third, formation of the 90- and
30-kD fragments was evident upon incubation of p115 with
7–25 nM caspases 3 and 8, whereas generation of the other
polypeptides required 
 
 
 
50–100 nM caspases (Fig. 3 B).
Fourth, time course experiments indicated that the genera-
tion of the 90- and 30-kD fragments reached a plateau at
 
 
 
10 min of incubation with purified caspase-3, whereas
production of the 75- and 50-kD fragments required 
 
 
 
180
min of incubation (Fig. 3 C). Finally, the full-length p115
TEKD
 
757Ala
 
 mutant was not cleaved when expressed in apop-
totic COS7 cells (Fig. 3 D)
 
,
 
 further supporting the idea that
the 90- and 30-kD fragments are the only bona fide p115
cleavage fragments in vivo.
Site-directed mutagenesis of p115 demonstrated that cleav-
age at TEKD
 
757
 
 released the 90- and 30-kD cleavage frag-
ments. We hypothesized that cleavage of p115 at this site
contributes to apoptotic Golgi fragmentation. To test this hy-
pothesis directly, two approaches can be used (both of which
we have used) to evaluate the physiological significance of this
caspase cleavage (Roy and Nicholson, 2000). The first ap-
proach involves expressing a cleavage-resistant mutant of
p115 to determine if it delays Golgi fragmentation during ap-
optosis. Our data demonstrate that this was the case; expres-
sion of the p115 TEKD
 
757Ala
 
 mutant delayed fragmentation
of the Golgi apparatus when compared with expression of the
native polypeptide (Table I). Although Golgi fragmentation
was delayed, the kinetics of apoptosis were not altered signifi-
cantly in these cells. However, because the apoptotic response
involves multiple pathways and components that are func-
tionally redundant, it is unlikely that inactivating one down-
stream signaling molecule would delay or inhibit apoptosis.
Furthermore, similar to many caspases and Bcl-2 family
members (Earnshaw et al., 1999; Strasser et al., 2000), the re-
quirement of the COOH-terminal p115 fragment in apopto-
sis may be both cell type and stimulus dependent.
The second approach is to express the caspase cleavage
fragments in healthy cells and demonstrate that they can dis-
rupt the normal Golgi structure directly by acting in a dom-
Table III. The COOH-terminal fragment of p115 induces Golgi fragmentation and apoptosis independently in COS7 cells
Transfected constructs Cell morphology Intact Golgi Fragmented Golgi
%%
COOH-terminal fragment alone Apoptotic 7.0 93.0
COOH-terminal fragment   z-VAD-fmk Normal 23.5 76.5
COOH-terminal fragment   TEKD757Ala p115 Apoptotic 40.5 59.5
Results are the averages of duplicate samples from two separate experiments. In each case, 100–200 cells were counted by two independent observers.646 The Journal of Cell Biology | Volume 159, Number 4, 2002
inant negative manner. Expression of the two p115 frag-
ments generated by cleavage at TEKD757 indicated that the
COOH-terminal fragment, p115758–962, disrupted the Golgi
structure and, surprisingly, also translocated to the nucleus
and induced apoptosis. These effects were not a consequence
of overexpression because neither full-length p115 nor
p1151–757 expressed at similar levels to the COOH-terminal
fragment had an effect on Golgi structure or cell viability.
Indeed, even 33 h after transfection, when expression of
both full-length p115 and p1151–757 reached extreme levels,
the percentage of transfected cells with apoptotic features re-
mained  20% (Table II). These results strongly support the
idea that p115 is required for maintaining normal Golgi
structure and its cleavage at TEKD757 contributes to apop-
totic signaling and fragmentation of the Golgi apparatus.
Considerable evidence has implicated the COOH-termi-
nal acidic region of p115 in mediating vesicle tethering at
the Golgi apparatus (Nelson et al., 1998; Dirac-Svejstrup et
al., 2000). It was shown to be the binding site for both gian-
tin and GM130 (Linstedt et al., 2000). Furthermore, this
domain also possesses the phosphorylated serine (residue
941/942) that regulates p115 affinity for GM130 and gian-
tin (Sohda et al., 1998; Dirac-Svejstrup et al., 2000). Recent
observations (Puthenveedu and Linstedt, 2001) have also
demonstrated that the Golgi undergoes COPI-dependent
fragmentation after microinjection of antibodies against
p115. In this context, our data are consistent with the idea
that the p115 COOH-terminal fragment has two indepen-
dent functions: one in disrupting Golgi structure by acting
as a dominant negative of p115, and the other in translocat-
ing to the nucleus and inducing apoptosis. In support for
this idea, we demonstrated that Golgi fragmentation and ap-
optosis induced by the COOH-terminal fragment could be
uncoupled in coexpression and caspase inhibitor studies
(Fig. 7, A and B). Furthermore, a deletion mutant of the ex-
treme COOH-terminal acidic domain was able to effect nu-
clear translocation, Golgi fragmentation, and apoptosis (Fig.
7 C). These data suggested that in addition to the acidic
stretch, other motifs in the COOH-terminal region contrib-
ute to the maintenance of Golgi structure and that the acidic
domain was not required to induce apoptosis. Like p115, it
is possible that additional cellular proteins that normally
have functions unrelated to apoptosis may become pro-apop-
totic factors once they are cleaved. For example, the neu-
ronal microtubule-associated protein tau is also a substrate
for caspase-3. Importantly, the percentage of cells expressing
tau cleavage fragments that were apoptotic increased two- to
threefold when compared with cells expressing the full-
length tau protein (Fasulo et al., 2000).
In the caspase-9–dependent apoptotic pathway, the mito-
chondrion is considered to be the central organelle responsi-
ble for sensing and inducing the apoptotic response through
molecules such as cytochrome c, apoptosis-inducing factor,
and proteins of the Bcl-2 family (Desagher and Martinou,
2000). By interacting with other pro-apoptotic molecules af-
ter its release from the mitochondria, cytochrome c forms
part of the apoptosome complex, which ultimately leads to
caspase activation and cell death (Zou et al.,1999). Previous
studies have suggested that the Golgi apparatus may also
play a role in apoptosis because pro-apoptotic molecules
such as caspase-2 and several death receptors were shown to
be concentrated in this organelle (An and Dou, 1996; Ben-
nett et al., 1998; Mancini et al., 2000; Zhang et al., 2000).
Our data provide further evidence in support of a role for
the Golgi apparatus in the apoptotic response.
An unexpected observation was that the p115758–962 frag-
ment localized efficiently to the nucleus in apoptotic cells
(Fig. 5). This was quite surprising because the p115
polypeptide lacks an obvious nuclear localization signal
and, to date, has not been reported to have a nuclear distri-
bution. We investigated this further by making use of an al-
gorithm that predicts protein subcellular localization based
on differences in amino acid composition (Reinhardt and
Hubbard, 1998). Significantly, the nonapoptosis-inducing
NH2-terminal fragment of p115 was predicted to be cyto-
plasmic with 55% reliability, whereas the COOH-terminal
p115758–962 fragment was predicted to be nuclear with 94%
reliability. In addition, a recent report demonstrated that a
subset of golgin-160 caspase cleavage fragments also trans-
located to the nucleus (Hicks and Machamer, 2002).
Whether these fragments are capable of eliciting the apop-
totic response is not known. One attractive model is that
the NH2 terminus of full-length p115 normally impedes
the nuclear translocation of its COOH-terminal domain in
healthy cells. However, once the NH2 terminus is cleaved
during apoptosis, the COOH-terminal fragment translo-
cates to the nucleus, where it may interact with and activate
pro-apoptotic factors, thereby propagating or potentiating
the upstream apoptotic signal. Experiments to identify pos-
sible nuclear targets of the p115758–962 fragment are cur-
rently in progress.
Materials and methods
Antibodies and reagents
Affinity-purified rabbit anti–phospho-GM130 antibody (PS25) and rabbit
anti-GM130 antibody were provided by Martin Lowe (University of
Manchester, Manchester, UK) and Graham Warren (Yale University School
of Medicine, New Haven, CT), respectively. A polyclonal antibody specific
for the COOH terminus of p115 was a gift from Adam Linstedt (Carnegie
Mellon University, Pittsburgh, PA). Polyclonal antibodies to p115 were
also provided by Elizabeth Sztul (University of Alabama, Birmingham, AL).
Polyclonal TGN38 antibody was a gift from Sharon Milgram (University of
North Carolina, Chapel Hill, NC). Monoclonal anti-GM130, anti-p115,
and anti-Vtila antibodies were purchased from Transduction Laboratories.
Antibodies against cleaved PARP and activated caspase-3 were purchased
from Promega. An antibody recognizing full-length PARP was purchased
from Cell Signaling. Alexa
® Fluor goat anti–mouse and anti–rabbit antibod-
ies were purchased from Molecular Probes, Inc. An agonistic anti-Fas anti-
body (clone CH11) was purchased from Upstate Biotechnology. The
pSG5-FLAG–human p115 construct was provided by Yukio Ikehara (Fuku-
oka University School of Medicine, Fukuoka, Japan). The pBluescriptII-
bovine p115 plasmid and four different anti-p115 monoclonal antibod-
ies were gifts from Gerry Waters (Princeton University, Princeton, NJ).
Caspases 2, 3, 7, and 8 were purified as previously described (Garcia-
Calvo et al., 1999) and were gifts of Nancy A. Thornberry (Merck Research
Laboratories, Rahway, NJ). A plasmid encoding procaspase-3 was provided
by Tom Gilmore (Boston University, Boston, MA). Staurosporine, etopo-
side, and cycloheximide were purchased from Sigma-Aldrich. z-VAD-fmk
and z-YVAD-fmk caspase inhibitors were purchased from Calbiochem.
Apoptosis induction
COS7, HeLa, and normal rat kidney (NRK) cells were grown in DME sup-
plemented with 10% FCS. Pheochromocytoma (PC12) cells were grown in
F-10 medium containing 2.5% FCS and 15% equine serum. 0.5–1  M
staurosporine or 80–100  M etoposide was added to the growth medium Role of p115 in Golgi fragmentation and apoptosis | Chiu et al. 647
for the indicated times at 37 C to induce apoptosis. Fas ligation was in-
duced as shown previously (Nguyen et al., 2000) using 0.5  g/ml agonistic
anti-Fas antibody in the presence of 10  g/ml cycloheximide for the indi-
cated times at 37 C.
Immunofluorescence and electron microscopy
Cells were grown on coverslips and treated as indicated. Samples were
fixed and processed for immunofluorescence microscopy as previously de-
scribed (Austin and Shields, 1996). Images were processed using IPLab
and Adobe Photoshop
®. Hoechst staining was performed after secondary
antibody incubation for 10 min in PBS. For PS25 staining, samples were
fixed in 100% methanol for 6 min at  20 C before antibody incubations.
Cells treated as indicated were fixed and processed for electron micros-
copy as previously described (Siddhanta et al., 2000).
Lysate preparation and Western blotting
After induction of apoptosis, cells were lysed as previously described (Roy
and Nicholson, 2000) and 30  g of each sample was loaded on a 10%
SDS polyacrylamide gel after which the polypeptides were transferred to
an Immobilon-P membrane (Millipore Corp.). Membranes were incubated
with the appropriate antibodies and the bands visualized by ECL (Amer-
sham Biosciences). For the caspase inhibitor studies, cells were preincu-
bated with 0.1 mM z-VAD-fmk or z-YVAD-fmk for 1 h at 37 C before apop-
tosis induction.
In vitro caspase cleavage reactions
Human and bovine p115 cDNAs were transcribed and translated using the
in vitro TNT-coupled reticulocyte lysate system (Promega). 5  l of the
translation product was incubated with the indicated concentration of pu-
rified caspases for 1 h at 37 C. Reactions were performed in buffer A (100
mM Hepes, pH 7.0, 10% sucrose, 0.1% CHAPS, 10 mM DTT) for caspases
3, 7, and 8, or buffer B (100 mM Mes, pH 6.5, 10% sucrose, 0.1% CHAPS,
10 mM DTT) for caspase-2. Caspase-7 reactions were performed in buffer
A supplemented with 5 mM CaCl2; SDS gel loading buffer was added to
each reaction at the end of the incubation. The samples were boiled and
loaded on a 10% SDS polyacrylamide gel. The gel was dried and analyzed
by fluorography.
Vector construction and transfection
The p115 D757A mutant was generated using the QuikChange site-
directed mutagenesis kit (Stratagene) using primer C1 (5 -CAATCATA-
GAGGCCTTTTCAGTCAGCTGGC-3 ) and primer C2 (5 -GCCAGCT-
GACTGAAAAGGCCTCTATGATTG-3 ). All mutations were confirmed by
automated DNA sequencing. To generate constructs expressing wild-
type p115 and truncated p115 fragments, PCR was performed using the
pSG5-FLAG–p115 plasmid as the template. Primers A (5 -CACGGATC-
CAATTTCCTCCGCGGGGTAATGGGG-3 ) and B (5 -GTGCTCGAGTTA-
TCAGATATGATCTAGATCCTTGCCAGGATC-3 ) were used to generate
the full-length coding region of human p115. Primers A and C (5 -GTG-
CTCGAGTTATCAATCCTCTTGGTCTCCAGATTCAAGTTC-3 ) and primers
D (5 -CACGGATCCTCTATGATTGAAAATATGAAATCTTCCC-3 ) and B
were used to generate the NH2-terminal and COOH-terminal p115 trunca-
tion mutants, respectively. All primers incorporate a BamHI site at the 5 
end and an XhoI site at the 3  end of each construct (underlined). PCR
products were digested with BamHI and XhoI and then purified using the
QIAquick PCR purification kit (QIAGEN). The purified inserts were FLAG
tagged at the NH2 terminus by subcloning into the pCMV-Tag2B mamma-
lian expression vector (Stratagene). 1  g of each plasmid was transfected
into COS7 cells growing on coverslips using the Effectene transfection re-
agent (QIAGEN).
Online supplemental material
Supplemental figures are available online at http://www.jcb.org/cgi/content/
full/jcb.200208013/DC1. Fig. S1 shows the fragmentation of the Golgi ap-
paratus into vesicular and tubular structures in cells treated with stauro-
sporine and etoposide. Fig. S2 demonstrates that the results of Fig. 7 are
identical when TGN38 was used as a Golgi marker instead of GM130.
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